Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritis

Joint Bone Spine

Volumn 71, Issue 6, 2004, Pages 493-502

  Sebbag, Mireille ^a   Chapuy Regaud, Sabine ^a   Auger, Isabelle ^b   Petit Texeira, Elisabeth ^c   Clavel, Cyril ^a   Nogueira, Leonor ^a   Vincent, Christian ^a   Corńlis, Fraņois ^c   Roudier, Jean ^b   Serre, Guy ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b INSERM   (France)

^c University of Evry Val d'Essonne   (France)

Author keywords

Citrullinated peptides; RA

Indexed keywords

ARGININE; AUTOANTIBODY; CITRULLINATED PROTEIN ANTIBODY; CYTOKERATIN 1; FC RECEPTOR; FIBRIN; FILAGGRIN; ISOPROTEIN; KERATIN ANTIBODY; PROTEIN; PROTEIN ANTIBODY; PROTEIN ARGININE DEIMINASE; RITUXIMAB; UNCLASSIFIED DRUG; VIMENTIN;

ALPHA CHAIN; AMINO ACID SEQUENCE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BETA CHAIN; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GENETIC CODE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOCHEMISTRY; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYNOVIUM; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; CITRULLINE; HUMANS; PROTEINS;

EID: 10344230419     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2004.07.004     Document Type: Conference Paper

References (100)

1. B.J. Young, R.K. Mallya, R.D. Leslie, C.J. Clark, and T.J. Hamblin Anti-keratin antibodies in rheumatoid arthritis BMJ 2 1979 97 99
2. G.D. Johnson, A. Carvalho, E.J. Holborow, D.H. Goddard, and G. Russell Antiperinuclear factor and keratin antibodies in rheumatoid arthritis Ann. Rheum. Dis. 40 1981 263 266
3. F.P. Quismorio Jr., R.L. Kaufman, T. Beardmore, and E.S. Mongan Reactivity of serum antibodies to the keratin layer of rat esophagus in patients with rheumatoid arthritis Arthritis Rheum. 26 1983 494 499
4. G. Serre, C. Vincent, B. Fourní, F. Lapeyre, J.P. Soleilhavoup, and A. Fourní Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects Rev. Rhum. Mal. Osteoartic. 53 1986 607 614
5. C. Vincent, G. Serre, F. Lapeyre, B. Fourní, C. Ayrolles, and A. Fourní High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies' Ann. Rheum. Dis. 48 1989 712 722
6. M. Simon, E. Girbal, M. Sebbag, V. Gom̀s-Daudrix, C. Vincent, and G. Salama The cytokeratin filament-aggregating protein filaggrin is the target of the so-called antikeratin antibodies, autoantibodies specific for rheumatoid arthritis J. Clin. Invest. 92 1993 1387 1393
7. E. Girbal, M. Sebbag, V. Gom̀s-Daudrix, M. Simon, C. Vincent, and G. Serre Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis Ann. Rheum. Dis. 52 1993 749 757
8. R.L.F. Nienhuis, and E. Mandema A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor Ann. Rheum. Dis. 23 1964 302 305
9. M. Sebbag, M. Simon, C. Vincent, C. Masson-Bessìre, E. Girbal, and J.J. Durieux The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 95 1995 2672 2679
10. C.R. Harding, and I.R. Scott Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation J. Mol. Biol. 170 1983 651 673
11. T. Senshu, S. Kan, H. Ogawa, M. Manabe, and H. Asaga Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis Biochem. Biophys. Res. Commun. 225 1996 712 719
12. M. Simon, C. Vincent, M. Haftek, E. Girbal, M. Sebbag, and V. Gom̀s-Daudrix The rheumatoid arthritis-associated autoantibodies to filaggrin label the fibrous matrix of the cornified cells but not the profilaggrin-containing keratohyalin granules in human epidermis Clin. Exp. Immunol. 100 1995 90 98
13. S.Q. Gan, O.W. McBride, W.W. Idler, N. Markova, and P.M. Steinert Organization, structure, and polymorphisms of the human profilaggrin gene Biochemistry 29 1990 9432 9440
14. E. Girbal-Neuhauser, J.J. Durieux, M. Arnaud, P. Dalbon, M. Sebbag, and C. Vincent The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues J. Immunol. 162 1999 585 594
15. G.A. Schellekens, B.A. De:Jong, F.H. Van:den:Hoogen, L.B. Van:de:Putte, and W.J. Van:Venrooij Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies J. Clin. Invest. 101 1998 273 281
16. A. Union, L. Meheus, R.L. Humbel, K. Conrad, G. Steiner, and H. Moereels Identification of citrullinated rheumatoid arthritis-specific epitopes in natural filaggrin relevant for antifilaggrin autoantibody detection by line immunoassay Arthritis Rheum. 46 2002 1185 1195
17. C. Masson-Bessìre, M. Sebbag, J.J. Durieux, L. Nogueira, C. Vincent, and E. Girbal-Neuhauser In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum Clin. Exp. Immunol. 119 2000 544 552
18. C. Masson-Bessìre, M. Sebbag, E. Girbal-Neuhauser, L. Nogueira, C. Vincent, and T. Senshu The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin J. Immunol. 166 2001 4177 4184
19. E.R. Vossenaar, N. Despres, E. Lapointe, A. Van:Der:Heijden, M. Lora, and T. Senshu Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin Arthritis Res. Ther. 6 2004 R142 R150
20. V. Gom̀s-Daudrix, M. Sebbag, E. Girbal, C. Vincent, M. Simon, and J. Rakotoarivony Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis Ann. Rheum. Dis. 53 1994 735 742
21. C. Vincent, M. Simon, M. Sebbag, E. Girbal-Neuhauser, J.J. Durieux, and A. Cantagrel Immunoblotting detection of autoantibodies to human epidermis filaggrin: a new diagnostic test for rheumatoid arthritis J. Rheumatol. 25 1998 838 846
22. C. Vincent, F. De:Keyser, C. Masson-Bessìre, M. Sebbag, E.M. Veys, and G. Serre Anti-perinuclear factor compared with the so called antikeratin antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides Ann. Rheum. Dis. 58 1999 42 48
23. L. Nogueira, M. Sebbag, C. Vincent, M. Arnaud, B. Fourní, and A. Cantagrel Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis Ann. Rheum. Dis. 60 2001 882 887
24. K. Suzuki, T. Sawada, A. Murakami, T. Matsui, S. Tohma, and K. Nakazono High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis Scand. J. Rheumatol. 32 2003 197 204
25. C. Vincent, L. Nogueira, M. Sebbag, S. Chapuy-Regaud, M. Arnaud, and O. Letourneur Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis Arthritis Rheum. 46 2002 2051 2058
26. L. Nogueira, A. Foussadier, C. Vincent, C. Clavel, N. Moinard, and M. Jolivet VIDAS-EDRA fully automated testing of autoantibodies to citrullinated proteins for the diagnosis of rheumatoid arthritis Arthritis Res. Ther. 6 2004 14
27. G.A. Schellekens, H. Visser, B.A. de:Jong, F.H. Van:den:Hoogen, J.M. Hazes, and F.C. Breedveld The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide Arthritis Rheum. 43 2000 155 163
28. E.R. Vossenaar, and W.J. Van:Venrooij Anti-CCP antibodies, a highly specific marker for (early) rheumatoid arthritis Clin. Appl. Immunol. Rev. 4 2004 239 262
29. N. Nogueira, M. Sebbag, S. Chapuy-Regaud, C. Clavel, B. Fourní, and A. Cantagrel Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for the diagnosis of rheumatoid arthritis Arthritis Res. 4 2002 90
30. J.M. Berthelot, Y. Maugars, A. Castagne, M. Audrain, and A. Prost Antiperinuclear factors are present in polyarthritis before ACR criteria for rheumatoid arthritis are fulfilled Ann. Rheum. Dis. 56 1997 123 125
31. R. Goldbach-Mansky, J. Lee, A. McCoy, J. Hoxworth, C. Yarboro, and J.S. Smolen Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset Arthritis Res. 2 2000 236 243
32. L. Paimela, T. Palosuo, K. Aho, M. Lukka, P. Kurki, and M. Leirisalo-Repo Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis Ann. Rheum. Dis. 60 2001 32 35
33. A.L. Jansen, I. Van:der:Horst-Bruinsma, D. Van:Schaardenburg, R.J. Van:de:Stadt, M.H. de:Koning, and B.A. Dijkmans Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis J. Rheumatol. 29 2002 2074 2076
34. L. Nogueira, S. Chapuy-Regaud, A. Constantin, C. Clavel, M. Sebbag, and A. Cantagrel Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis Arthritis Res. Ther. 5 2003 18
35. F.A. Van:Gaalen, S.P. Linn-Rasker, W.J. Van:Venrooij, B.A. de:Jong, F.C. Breedveld, and C.L. Verweij Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study Arthritis Rheum. 50 2004 709 715
36. P. Kurki, K. Aho, T. Palosuo, and M. Heliovaara Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease Arthritis Rheum. 35 1992 914 917
37. S. Rantapaa-Dahlqvist, B.A. de:Jong, E. Berglin, G. Hallmans, G. Wadell, and H. Stenlund Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis Arthritis Rheum. 48 2003 2741 2749
38. M.M. Nielen, D. Van:Schaardenburg, H.W. Reesink, R.J. Van:de:Stadt, I.E. Van:der:Horst-Bruinsma, and M.H. de:Koning Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors Arthritis Rheum. 50 2004 380 386
39. L. Paimela, M. Gripenberg, P. Kurki, and M. Leirisalo-Repo Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis Ann. Rheum. Dis. 51 1992 743 746
40. S. Bas, T.V. Perneger, E. Mikhnevitch, M. Seitz, J.M. Tiercy, and P. Roux-Lombard Association of rheumatoid factors and anti-filaggrin antibodies with severity of erosions in rheumatoid arthritis Rheumatology (Oxford) 39 2000 1082 1088
41. S. Munoz-Fernandez, R. Alvarez-Doforno, J.M. Gonzalez-Tarrio, A. Balsa, P. Richi, and G. Fontan Antiperinuclear factor as a prognostic marker in rheumatoid arthritis J. Rheumatol. 26 1999 2572 2577
42. K. Forslin, C. Vincent, G. Serre, and B. Svensson Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression Scand. J. Rheumatol. 30 2001 221 224
43. H. Visser, S. Le:Cessie, K. Vos, F.C. Breedveld, and J.M. Hazes How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis Arthritis Rheum. 46 2002 357 365
44. O. Meyer, C. Labarre, M. Dougados, P. Goupille, A. Cantagrel, and A. Dubois Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage Ann. Rheum. Dis. 62 2003 120 126
45. J. Vencovsky, S. Machacek, L. Sedova, J. Kafkova, J. Gatterova, and V. Pesakova Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis Ann. Rheum. Dis. 62 2003 427 430
46. L. De:Rycke, I. Peene, I.E.A. Hoffman, E. Kruithof, A. Union, and L. Meheus Rheumatoid factor and anti-citrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations Ann. Rheum. Dis. 2004 (in press)
47. S. De:Vita, F. Zaja, S. Sacco, A. De:Candia, R. Fanin, and G. Ferraccioli Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells Arthritis Rheum. 46 2002 2029 2033
48. G. Cambridge, M.J. Leandro, J.C. Edwards, M.R. Ehrenstein, M. Salden, and M. Bodman-Smith Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis Arthritis Rheum. 48 2003 2146 2154
49. J.C. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, and D.R. Close Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N. Engl. J. Med. 350 2004 2572 2581
50. J.B. Weinberg, A.M. Pippen, and C.S. Greenberg Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis Arthritis Rheum. 34 1991 996 1005
51. L.R. Zacharski, F.E. Brown, V.A. Memoli, W. Kisiel, B.J. Kudryk, and S.M. Rousseau Pathways of coagulation activation in situ in rheumatoid synovial tissue Clin. Immunol. Immunopathol. 63 1992 155 162
52. H.K. Ronday, H.H. Smits, G.N. Van:Muijen, M.S. Pruszczynski, R.J. Dolhain, and E.J. Van:Langelaan Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis Br. J. Rheumatol. 35 1996 416 423
53. N. Busso, V. Peclat, K. Van:Ness, E. Kolodziesczyk, J. Degen, and T. Bugge Exacerbation of antigen-induced arthritis in urokinase-deficient mice J. Clin. Invest. 102 1998 41 50
54. P.A. Varisco, V. Peclat, K. Van:Ness, A. Bischof-Delaloye, A. So, and N. Busso Effect of thrombin inhibition on synovial inflammation in antigen induced arthritis Ann. Rheum. Dis. 59 2000 781 787
55. Y.H. Yang, P. Carmeliet, and J.A. Hamilton Tissue-type plasminogen activator deficiency exacerbates arthritis J. Immunol. 167 2001 1047 1052
56. E.R. Vossenaar, S. Nijenhuis, M.M. Helsen, A. Van:der:Heijden, T. Senshu, and W.B. Van:den:Berg Citrullination of synovial proteins in murine models of rheumatoid arthritis Arthritis Rheum. 48 2003 2489 2500
57. K. Forslin, C. Vincent, G. Serre, and B. Svensson Antifilaggrin autoantibodies in early rheumatoid arthritis Scand. J. Rheumatol. 29 2000 320 322
58. E.J. Kroot, B.A. de:Jong, M.A. Van:Leeuwen, H. Swinkels, F.H. Van:den:Hoogen, and M. Van't:Hof The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis Arthritis Rheum. 43 2000 1831 1835
59. D. Reviron, A. Perdriger, E. Toussirot, D. Wendling, N. Balandraud, and S. Guis Influence of shared epitope-negative HLA-DRB1 alleles on genetic susceptibility to rheumatoid arthritis Arthritis. Rheum. 44 2001 535 540
60. J.A. Hill, S. Southwood, A. Sette, A.M. Jevnikar, D.A. Bell, and E. Cairns Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule J. Immunol. 171 2003 538 541
61. M. Guerrin, A. Ishigami, M.C. Ḿchin, R. Nachat, S. Valmary, and M. Sebbag cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I Biochem. J. 370 2003 167 174
62. A. Ishigami, T. Ohsawa, H. Asaga, K. Akiyama, M. Kuramoto, and N. Maruyama Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin Arch. Biochem. Biophys. 407 2002 25 31
63. T. Kanno, A. Kawada, J. Yamanouchi, C. Yosida-Noro, A. Yoshiki, and M. Shiraiwa Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin J. Invest. Dermatol. 115 2000 813 823
64. K. Nakashima, T. Hagiwara, A. Ishigami, S. Nagata, H. Asaga, and M. Kuramoto Molecular characterization of peptidylarginine deiminase in HL-60 cells induced by retinoic acid and 1alpha,25-dihydroxyvitamin D(3) J. Biol. Chem. 274 1999 27786 27792
65. S. Chavanas, M.C. Ḿchin, H. Takahara, A. Kawada, R. Nachat, and G. Serre Comparative analysis of the mouse and human peptidylarginine deiminase gene clusters reveals highly conserved non-coding segments and a new human gene, PADI6 Gene. 330 2004 19 27
66. Y. Urano, K. Watanabe, A. Sakaki, S. Arase, Y. Watanabe, and F. Shigemi Immunohistochemical demonstration of peptidylarginine deiminase in human sweat glands Am. J. Dermatopathol. 12 1990 249 255
67. E.R. Vossenaar, T.R. Radstake, A. Van:der Heijden, M.A. Van:Mansum, C. Dieteren, and D.J. de:Rooij Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages Ann. Rheum. Dis. 63 2004 373 381
68. G. Rogers, B. Winter, C. McLaughlan, B. Powell, and T. Nesci Peptidylarginine deiminase of the hair follicle: characterization, localization, and function in keratinizing tissues J. Invest. Dermatol. 108 1997 700 707
69. K. Nakashima, T. Hagiwara, and M. Yamada Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes J. Biol. Chem. 277 2002 49562 49568
70. G.E. Rogers, H.W. Harding, and I.J. Llewellyn-Smith The origin of citrulline-containing proteins in the hair follicle and the chemical nature of trichohyalin, an intracellular precursor Biochim. Biophys. Acta 495 1977 159 175
71. T. Senshu, K. Akiyama, S. Kan, H. Asaga, A. Ishigami, and M. Manabe Detection of deiminated proteins in rat skin: probing with a monospecific antibody after modification of citrulline residues J. Invest. Dermatol. 105 1995 163 169
72. D.D. Wood, and M.A. Moscarello The isolation, characterization, and lipid-aggregating properties of a citrulline containing myelin basic protein J. Biol. Chem. 264 1989 5121 5127
73. A.P. Nicholas, T. Sambandam, J.D. Echols, and W.W. Tourtellotte Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis J. Comp. Neurol. 473 2004 128 136
74. M. Inagaki, H. Takahara, Y. Nishi, K. Sugawara, and C. Sato Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain J. Biol. Chem. 264 1989 18119 18127
75. E. Tarcsa, L.N. Marekov, G. Mei, G. Melino, S.C. Lee, and P.M. Steinert Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and filaggrin J. Biol. Chem. 271 1996 30709 30716
76. N. Ishiyama, I.R. Bates, C.M. Hill, D.D. Wood, P. Matharu, and N.J. Viner The effects of deimination of myelin basic protein on structures formed by its interaction with phosphoinositide-containing lipid monolayers J. Struct. Biol. 136 2001 30 45
77. Y. Tsuji, M. Akiyama, K. Arita, T. Senshu, and H. Shimizu Changing pattern of deiminated proteins in developing human epidermis J. Invest. Dermatol. 120 2003 817 822
78. M.A. Moscarello, D.D. Wood, C. Ackerley, and C. Boulias Myelin in multiple sclerosis is developmentally immature J. Clin. Invest. 94 1994 146 154
79. I.R. Scott, C.R. Harding, and J.G. Barrett Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum Biochim. Biophys. Acta 719 1982 110 117
80. H. Asaga, M. Yamada, and T. Senshu Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages Biochem. Biophys. Res. Commun. 243 1998 641 646
81. M. Mizoguchi, M. Manabe, Y. Kawamura, Y. Kondo, K. Ishidoh, and E. Kominami Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro J. Histochem. Cytochem. 46 1998 1303 1309
82. T. Hagiwara, K. Nakashima, H. Hirano, T. Senshu, and M. Yamada Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes Biochem. Biophys. Res. Commun. 290 2002 979 983
83. M.A. Moscarello, L. Pritzker, F.G. Mastronardi, and D.D. Wood Peptidylarginine deiminase: a candidate factor in demyelinating disease J. Neurochem. 81 2002 335 343
84. F. Corńlis, S. Faure, M. Martinez, J.F. Prud'homme, P. Fritz, and C. Dib New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study Proc. Natl. Acad. Sci. USA 95 1998 10746 10750
85. S. Shiozawa, S. Hayashi, Y. Tsukamoto, H. Goko, H. Kawasaki, and T. Wada Identification of the gene loci that predispose to rheumatoid arthritis Int. Immunol. 10 1998 1891 1895
86. D. Jawaheer, M.F. Seldin, C.I. Amos, W.V. Chen, R. Shigeta, and J. Monteiro A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases Am. J. Hum. Genet. 68 2001 927 936
87. K. MacKay, S. Eyre, A. Myerscough, A. Milicic, A. Barton, and S. Laval Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom Arthritis. Rheum. 46 2002 632 639
88. D. Jawaheer, M.F. Seldin, C.I. Amos, W.V. Chen, R. Shigeta, and C. Etzel Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families Arthritis. Rheum. 48 2003 906 916
89. J. Osorio y Fortea, H. Bukulmez, E. Petit-Teixeira, L. Michou, C. Pierlot, and S. Cailleau-Moindrault Dense genome-wide linkage analysis of rheumatoid arthritis including covariates Arthritis Rheum. 50 2004 2757 2765
90. A. Suzuki, R. Yamada, X. Chang, S. Tokuhiro, T. Sawada, and M. Suzuki Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat. Genet. 34 2003 395 402
91. A. Barton, J. Bowes, S. Eyre, K. Spreckley, A. Hinks, and S. John A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population Arthritis Rheum. 50 2004 1117 1121
92. D.D. Wood, J.M. Bilbao, P. O'Connors, and M.A. Moscarello Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein Ann. Neurol. 40 1996 18 24
93. A. Ishida-Yamamoto, T. Senshu, H. Takahashi, K. Akiyama, K. Nomura, and H. Iizuka Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis J. Invest. Dermatol. 114 2000 701 705
94. P.L. Van:Lent, A.J. Van:Vuuren, A.B. Blom, A.E. Holthuysen, L.B. Van:de:Putte, and J.G. Van:de:Winkel Role of Fc receptor gamma chain in inflammation and cartilage damage during experimental antigen-induced arthritis Arthritis Rheum. 43 2000 740 752
95. A.S. Korganow, H. Ji, S. Mangialaio, V. Duchatelle, R. Pelanda, and T. Martin From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins Immunity 10 1999 451 461
96. H. Ji, K. Ohmura, U. Mahmood, D.M. Lee, F.M. Hofhuis, and S.A. Boackle Arthritis critically dependent on innate immune system players Immunity 16 2002 157 168
97. C. Vincent, G. Serre, J.P. Basile, H.C. Lestra, E. Girbal, and M. Sebbag Subclass distribution of IgG antibodies to the rat oesophagus stratum corneum (so-called anti-keratin antibodies) in rheumatoid arthritis Clin. Exp. Immunol. 81 1990 83 89
98. S. Chapuy-Regaud, L. Nogueira, C. Clavel, M. Sebbag, C. Vincent, and G. Serre Subclass distribution of IgG autoantibodies to deiminated fibrinogen in rheumatoid arthritis Arthritis Res. Ther. 5 2003 4
99. D.C. Dumonde, and L.E. Glynn The production of arthritis in rabbits by an immunological reaction to fibrin Br. J. Exp. Pathol. 43 1962 373 383
100. F.C. Arnett, S.M. Edworthy, D.A. Bloch, D.J. McShane, J.F. Fries, and N.S. Cooper The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum. 31 1988 315 324